Developed by Shray Alag, The Harker School
Sections: Correlations,
Clinical Trials, and HPO
Navigate: Clinical Trials and HPO
Navigate: Correlations HPO
There is one clinical trial.
This pilot study is designed to evaluate the potential effectiveness of the implementation strategy and intervention delivery model of a community paramedic coaching program for caregivers of persons with dementia, in direct coordination with the participant and caregiver's primary health care team. Specifically, the acceptability, appropriateness, and feasibility of the program will be assessed, collecting data from all implementation stakeholders at baseline, 13 weeks, 25 weeks, and post-intervention (~50 weeks) using quantitative survey instruments and qualitative interviews.
Description: As determined by abstracting the medical records, the investigators are testing the hypothesis that the number of visits to the Emergency Department is lower than commonly reported in the literature for persons with dementia.
Measure: Number of Visits to the Emergency Department by the Person with Dementia Time: up to 24 monthsDescription: As determined by abstracting the medical records, the investigators are testing the hypothesis that the number of visits to the Emergency Department is lower than commonly reported in the literature for average older adults.
Measure: Number of Visits to the Emergency Department by the Caregiver of the Person with Dementia Time: up to 24 monthsDescription: The intervention will be deemed feasible if at least 75% of the intended coaching phone calls are completed. The minimum number of coaching calls is 3, additional calls will be scheduled opposite weeks of home visits as needed.
Measure: Feasibility: Proportion of Coaching Phone Calls Completed Time: up to 12 monthsDescription: The intervention will be deemed feasible if at least 75% of the intended home visits are completed. The minimum number of intended home visits is 9.
Measure: Feasibility: Proportion of Coaching Home Visits Completed Time: up to 12 monthsDescription: The Zarit Burden Interview measures caregiver burden. This is a 12-item survey with a total possible range of scores from 0-48, where higher scores indicate increased burden. The investigators hypothesize the score will decrease as a result of the intervention.
Measure: Change in Zarit Burden Interview (ZBI-12) Score Time: First home visit (~ week 1), week 13, week 25, and last home visit (~up to week 50)Description: The GAD-7 is a 7-item survey that measures anxiety symptom severity. The total possible range of scores is 0-21, where higher scores indicate increased symptom severity. The investigators hypothesize the score will decrease as a result of the intervention.
Measure: Change in Generalized Anxiety Disorder (GAD-7) Score Time: Baseline, week 13, week 25, week 50Description: The CESD-10 is a general measure of depression frequently used in caregiver studies. It is a 10-item survey with a total possible range of scores of 0-30 where higher scores indicate increased depression. The investigators hypothesize the score will decrease as a result of the intervention.
Measure: Change in Center for Epidemiologic Studies Depression Scale (CESD-10) Time: First home visit (~ week 1), week 13, week 25, and last home visit (~up to week 50)Description: The RCSS is a 6-item survey used to measure the positive aspects of caring. The range of total possible scores is 6-30 where higher scores indicate increased caregiver satisfaction. The investigators hypothesize the score will increase as a result of the intervention.
Measure: Change in Revised Caregiving Satisfaction Scale (RCSS) Time: Baseline, week 13, week 25, week 50Description: The revised scale for caregiving self-efficacy measures three domains: obtaining respite, responding to disruptive patient behaviors, and controlling upsetting thoughts. It is a 15-item scale with a total possible range of scores between 0-100, where higher scores are better. The investigators hypothesize the score will increase as a result of the intervention.
Measure: Change in Revised Scale for Caregiving Self-Efficacy Time: First home visit (~ week 1) and last home visit (~up to week 50)Description: WFC is measured for the caregiver. It is a 6-item survey with a total possible range of scores between 6-30 with higher scores indicating lesser work-family conflict. The investigators hypothesize the score will increase as a result of the intervention.
Measure: Change in Work-Family Conflict Scale (WFC) Time: First home visit (~ week 1) and last home visit (~up to week 50)Description: C-DEMQOL is measured for the caregiver. The investigators will be asking 18 of the questions from the scale to understand the quality of life the caregivers experience. Scores can range from 18-90, with a higher score reflecting a higher quality of life.
Measure: Change in Caregiver Quality of Life (C-DEMQOL) Score Time: Baseline and 62 weeks (12 weeks post completion)Description: DKAS is measured for the caregiver. It is a 25 item true-false survey of facts about dementia. Scoring is by measuring the proportion of questions answered correctly.
Measure: Change in Knowledge of Dementia (DKAS) Score Time: Baseline and 62 weeks (12 weeks post completion)Description: As determined by abstracting the medical records, the investigators are characterizing the number of contacts with outpatient clinics for persons with dementia.
Measure: Clinic Utilization by Persons with Dementia Time: up to 24 monthsDescription: As determined by abstracting the medical records, the investigators are characterizing the number of contacts with outpatient clinics for caregivers of persons with dementia.
Measure: Clinic Utilization by Caregivers of Persons with Dementia Time: up to 24 monthsDescription: Assesses caregivers perception of communication with health care team and extent to which the team considers their capacity and preferences in decision making. This measure consists of 12 questions, with scores ranging from 12-60, where higher scores indicate increased communication with the health care team.
Measure: Change in Caregiver Perceptions About Communication With Clinical Team Members (CAPACITY) Measure Time: Baseline and 62 weeks (12 weeks post completion)Alphabetical listing of all HPO terms. Navigate: Correlations Clinical Trials
Data processed on September 26, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.
Drug Reports MeSH Reports HPO Reports